| Literature DB >> 28009983 |
Ling Li1, Mengmeng Zhi1, Zhenghua Hou2, Yuqun Zhang2, Yingying Yue2, Yonggui Yuan2,3.
Abstract
Patients with hyperthyroidism frequently have neuropsychiatric complaints such as lack of concentration, poor memory, depression, anxiety, nervousness, and irritability, suggesting brain dysfunction. However, the underlying process of these symptoms remains unclear. Using resting-state functional magnetic resonance imaging (rs-fMRI), we depicted the altered graph theoretical metric degree centrality (DC) and seed-based resting-state functional connectivity (FC) in 33 hyperthyroid patients relative to 33 healthy controls. The peak points of significantly altered DC between the two groups were defined as the seed regions to calculate FC to the whole brain. Then, partial correlation analyses were performed between abnormal DC, FC and neuropsychological performances, as well as some clinical indexes. The decreased intrinsic functional connectivity in the posterior lobe of cerebellum (PLC) and medial frontal gyrus (MeFG), as well as the abnormal seed-based FC anchored in default mode network (DMN), attention network, visual network and cognitive network in this study, possibly constitutes the latent mechanism for emotional and cognitive changes in hyperthyroidism, including anxiety and impaired processing speed.Entities:
Keywords: cognition; degree centrality; emotion; functional connectivity; hyperthyroidism
Mesh:
Year: 2017 PMID: 28009983 PMCID: PMC5351631 DOI: 10.18632/oncotarget.14060
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Demographic, clinical characteristics, mood and cognitive performances
| Characteristic | Hyperthyroidism | Control | |
|---|---|---|---|
| n | 33 | 33 | |
| Age (years) | 37.36 ± 12.43 | 39.03 ± 13.28 | 0.600a |
| Female, n (%) | 26.00(78.79) | 26.00(78.79) | 1.000b |
| Education levels (years) | 13.24 ± 3.82 | 13.70 ± 4.06 | 0.641a |
| BMI (kg/m2) | 21.61 ± 2.81 | 23.35 ± 2.55 | 0.011a |
| FT3 (pg/ml) | 14.17(8.98−23.59) | 3.02(2.77−3.33) | < 0.001c |
| TGAb (IU/mL) | 269.00(25.07−540.60) | 18.95(16.10−37.28) | < 0.001 |
| TPOAb (IU/mL) | 221.20(37.52−493.10) | 14.84(11.75−19.29) | < 0.001c |
| Drug use, n (%) | 15.00(45.45) | − | − |
| Disease duration (months) | 9.94 ± 17.31 | − | − |
| Neuropsychological test data (z-score) | |||
| Mood | |||
| HDRSd | 0.70 ± 0.97 | −0.70 ± 0.25 | < 0.001a |
| HARSd | 0.78 ± 0.85 | −0.78 ± 0.23 | < 0.001a |
| Processing Speed | −0.17 ± 0.89 | 0.17 ± 0.82 | 0.115a |
| Stroop Colord | −0.15 ± 1.09 | 0.15 ± 0.89 | 0.216a |
| Stroop Wordd | −0.17 ± 1.02 | 0.17 ± 0.97 | 0.174a |
| TMT-Ad | −0.18 ± 1.00 | 0.18 ± 0.98 | 0.140a |
| DSSTd | −0.17 ± 1.00 | 0.17 ± 0.98 | 0.169a |
| Executive Function | −0.24 ± 0.76 | 0.24 ± 0.71 | 0.011a |
| Stroop Inhibitiond | −0.03 ± 0.97 | 0.03 ± 1.04 | 0.807a |
| TMT-Bd | −0.25 ± 0.81 | 0.25 ± 1.12 | 0.042a |
| DSTd | −0.30 ± 0.99 | 0.30 ± 0.93 | 0.014a |
| VFT-1d | −0.34 ± 1.02 | 0.34 ± 0.87 | 0.005a |
| VFT-2d | −0.27 ± 1.13 | 0.27 ± 0.78 | 0.026a |
| Visuospatial Skills | −0.42 ± 0.92 | 0.42 ± 0.43 | < 0.001a |
| CFTd | −0.33 ± 1.27 | 0.33 ± 0.44 | 0.007a |
| CDTd | −0.51 ± 0.97 | 0.51 ± 0.74 | < 0.001a |
| Episodic Memory | −0.19 ± 0.87 | 0.19 ± 0.86 | 0.087a |
| AVLT-DRd | −0.06 ± 0.97 | 0.06 ± 1.04 | 0.611a |
| CFT-DRd | −0.31 ± 1.02 | 0.31 ± 0.89 | 0.011a |
Abbreviations: BMI = Body Mass Index, FT3 = Free Triiodothyronine, TGAb = Thyroglobulin Antibody, TPOAb = Thyroid Peroxidase Antibody, HDRS = Hamilton Depression Rating Scale, HARS = Hamilton Anxiety Rating Scale, Stroop Color Total Time = Color naming subtest scaled score, Stroop Word Total Time = Word naming subtest scaled score, Stroop Inhibition Time = inhibition subtest scaled score; TMT = Trail-Making Test, DSST = Digit Symbol Substitution Test, DST = digit span test, VFT = Verbal Fluency Test, CDT = clock-drawing test, CFT = Rey-Osterrieth complex figure test, CFT-DR = Rey-Osterrieth complex figure test delayed recall, AVLT-DR = auditory verbal learning test–delayed recall.
aTwo independent sample t-test.
bChi-square test.
cMann-Whitney rank test.
dScale scores were transformed to standard Z values in order to avoid the influence of the different measurement units.
Brain regions showing significantly different DC between HPs and HCs
| BA | Peak area | MNI coordinates | Voxels number | Peak t value | ||||
|---|---|---|---|---|---|---|---|---|
| X | Y | Z | ||||||
| DC | HPs < HCs | Left PLC | −15 | −66 | −48 | 143 | −3.50 | |
| 32/9 | Bilateral MeFG | −6 | 39 | −6 | 289 | −4.23 | ||
Note: Threshold was set at P < 0.05 (AlphaSim-corrected). X, Y, Z, coordinates of primary peak locations in the MNI space.
Abbreviations: MNI, Montreal Neurological Institute space; DC, degree centrality; HPs, hyperthyroid patients; HCs, health controls; BA, Brodmann area; PLC, cerebellum posterior lobe; MeFG, medial frontal gyrus.
Figure 1Significantly decreased (blue) DC in hyperthyroid patients
(P < 0.05, AlphaSim corrected). The color bar indicates the T value from two-sample t test between hyperthyroidism and healthy control group.
Brain regions showing significantly different functional connectivity between HPs and HCs
| Connected regions | BA | Peak area | MNI coordinates | Voxels number | Peak t value | ||
|---|---|---|---|---|---|---|---|
| X | Y | Z | |||||
| Seed point (−15, −66, −48) | |||||||
| 21 | Right MTG | 48 | 0 | −18 | 23 | −4.33 | |
| Seed point (−6, 39, −6) | |||||||
| Left PLC | −6 | −51 | −51 | 61 | −5.07 | ||
| Right cerebellum | 54 | −63 | −36 | 22 | −5.06 | ||
| 19 | Left IOG | −27 | −87 | −21 | 44 | −5.17 | |
| Left caudate | −15 | 21 | 3 | 22 | −4.13 | ||
| 7 | Bilateral PCu | −3 | −63 | 24 | 60 | −4.31 | |
| 9 | Bilateral MeFG | −6 | 42 | −9 | 243 | −5.80 | |
Note: Threshold was set at P < 0.001(AlphaSim-corrected). X, Y, Z, coordinates of primary peak locations in the MNI space.
Abbreviations: MNI, Montreal Neurological Institute space; HPs, hyperthyroid patients; HCs, health controls; BA, Brodmann area; MTG, middle temporal gyrus; PLC, posterior lobe of cerebellum; IOG, inferior occipital gyrus; PCu, precuneus; MeFG, medial frontal gyrus.
Figure 2Brain regions showing decreased functional connectivity (blue) with the seed-1 point (−15, −66, −48) in the hyperthyroid group compared with the control group (P < 0.001, AlphaSim corrected)
The color bar indicates the T value from two-sample t test between hyperthyroidism and healthy control group.
Figure 3Brain regions showing decreased functional connectivity (blue) with the seed-2 point (−6, 39, −6) in the hyperthyroid group compared with the control group (P < 0.001, AlphaSim corrected)
The color bar indicates the T value from two-sample t test between hyperthyroidism and healthy control group.
Figure 4Scatter diagrams show the significant correlations between the psychological assessment z-scores, clinical indexes and values of DC, FC in hyperthyroidism group
(A) DC in left PLC was in negative correlation with serum TPOAb (r = −0.48, P = 0.008); (B) FC between right cerebellum and MeFG was negatively correlated with HARS z scores (r = −0.48, P = 0.007); (C) FC between bilateral PCu and MeFG was negatively with processing speed z scores (r = −0.41, P = 0.026); (D) FC between bilateral PCu and MeFG was negatively with FT3 levels (r = −0.45, P = 0.013); (E) FC between left IOG and MeFG was positively correlated to TPOAb levels (r = 0.39, P = 0.035). HARS = Hamilton Anxiety Rating Scale, DC = Degree Centrality; FC = Functional Connectivity; PLC = Posterior Lobe of Cerebellum; MeFG = Medial Frontal Gyrus; PCu = Precuneus; IOG = Inferior Occipital Gyrus; r = Spearman's correlation coefficient.